Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
279.77 +7.43 / +2.73%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
279.35 -0.42 / -0.15%
 
Volume: 24.6K

Today’s Trading

Previous close272.34
Today’s open274.05
Day’s range274.05 - 282.32
Volume2,994,965
Average volume (3 months)4,105,627
Market cap$107.3B
Dividend yield--
Data as of 4:03pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+10.32%
Earnings growth (next 5 years)+10.02%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.06+0.10%
SNYSanofi-0.38-0.98%
GSKGlaxoSmithKline-0.21-0.53%
NVONovo Nordisk+1.33+2.86%
Data as of 4:02pm ET, 02/10/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$3.34
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers